Great Point Partners LLC Genfit S.A. Transaction History

Great Point Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$10.95 - $20.76 $2.28 Million - $4.31 Million	-207,766 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$13.55 - $20.14 $6.47 Million - $9.62 Million	-477,787 Reduced 69.69%	207,766 $4.14 Million
Q3 2019 Nov 15, 2019	SELL	$14.92 - $19.94 $129,804 - $173,478	-8,700 Reduced 1.25%	685,553 $11.9 Million
Q2 2019 Aug 14, 2019	SELL	$19.74 - $25.65 $10.6 Million - $13.7 Million	-536,061 Reduced 43.57%	694,253 $0
Q1 2019 May 14, 2019	BUY	$22.17 - $24.0 $27.3 Million - $29.5 Million	1,230,314 New	1,230,314 $29.5 Million

49.2K

Ticker GNFT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,815,500
Market Cap $274M
Description
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Great Point Partners LLC with notifications on news.